A detailed history of Wick Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wick Capital Partners, LLC holds 471 shares of LLY stock, worth $437,898. This represents 0.11% of its overall portfolio holdings.

Number of Shares
471
Previous 56,267 99.16%
Holding current value
$437,898
Previous $43.4 Million 99.16%
% of portfolio
0.11%
Previous 6.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

SELL
$727.2 - $932.06 $40.6 Million - $52 Million
-55,796 Reduced 99.16%
471 $363,000
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $40.6 Million - $52.1 Million
55,878 Added 14364.52%
56,267 $43.4 Million
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $6,949 - $8,640
9 Added 2.37%
389 $344,000
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $275,450 - $345,435
380 New
380 $344,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $883B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wick Capital Partners, LLC Portfolio

Follow Wick Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wick Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wick Capital Partners, LLC with notifications on news.